logo
Select company
Select metric
17.36%Debt to Assets Ratio
VS
Market
55
Sector
43
Industry
31
History
67
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 333.33M$ 57.86M17.36%
3/31/2025$ 138.36M$ 59.55M43.04%
12/31/2024$ 160.36M$ 61.3M38.23%
9/30/2024$ 180.22M$ 60.72M33.69%
6/30/2024$ 200.39M$ 55.97M27.93%
3/31/2024$ 153M$ 59.01M38.57%
12/31/2023$ 172.73M$ 59.46M34.42%
9/30/2023$ 195.77M$ 57.65M29.45%
6/30/2023$ 81.54M$ 57.88M70.98%
3/31/2023$ 101.6M$ 58.09M57.17%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) Debt to Assets stands at 0%.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average Debt to Assets has been 27.44%.
  • The median Debt to Assets for TAYSHA GENE THERAPIES INC during this period was 28.69%
  • TAYSHA GENE THERAPIES INC reached its highest Debt to Assets over the past 5 years at 70.98%.
  • The lowest Debt to Assets recorded by TAYSHA GENE THERAPIES INC in the same timeframe 0%

TAYSHA GENE THERAPIES INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
RLAY : RELAY THERAPEUTICS INC 4.69%PRAX : PRAXIS PRECISION MEDICINES INC 0.17%LENZ : LENZ THERAPEUTICS INC 0.26%DNTH : DIANTHUS THERAPEUTICS INC 0.41%IMNM : IMMUNOME INC 1.4%TNXP : TONIX PHARMACEUTICALS HOLDING CORP 0.26%PRME : PRIME MEDICINE INC 42.91%NUVB : NUVATION BIO INC 31.42%PGEN : PRECIGEN INC 5.06%ATAI : ATAI LIFE SCIENCES NV 4.87%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for TAYSHA GENE THERAPIES INC is calculated as follows: Debt [ $ 0 ] / Assets [ $ 279.27M ]
(=) Debt to Assets [ 0% ]

TSHA - Debt to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2020

70.98%

Maximum

Jun 30, 2023

27.44%

Average

28.69%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%